Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTD of Umbilical Cord MSCs in Knee OA
NCT03357770Phase 1Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised, double-blind trial of human umbilical cord mesenchymal stem cells in osteoarthritis (OA) (3 arms), sponsored by Peking University People's Hospital. Primary endpoint: Unexplained local and systemic symptoms or death at 6 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03357770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357770.